Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
Background/Aims Infectious complications are major concerns when treating patients with inflammatory bowel disease (IBD). This study evaluated clinical differences across countries/regions in the management of infectious diseases in patients with IBD. Methods A multinational online questionnaire sur...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Association for the Study of Intestinal Diseases
2023-07-01
|
| Series: | Intestinal Research |
| Subjects: | |
| Online Access: | http://irjournal.org/upload/pdf/ir-2023-00013.pdf |
| _version_ | 1797755764915306496 |
|---|---|
| author | Yu Kyung Jun Seong-Joon Koh Dae Seong Myung Sang Hyoung Park Choon Jin Ooi Ajit Sood Jong Pil Im |
| author_facet | Yu Kyung Jun Seong-Joon Koh Dae Seong Myung Sang Hyoung Park Choon Jin Ooi Ajit Sood Jong Pil Im |
| author_sort | Yu Kyung Jun |
| collection | DOAJ |
| description | Background/Aims Infectious complications are major concerns when treating patients with inflammatory bowel disease (IBD). This study evaluated clinical differences across countries/regions in the management of infectious diseases in patients with IBD. Methods A multinational online questionnaire survey was administered to participants at the 8th meeting of the Asian Organization for Crohn’s and Colitis. The questionnaire included questions regarding surveillance, diagnosis, management, and prevention of infection in patients with IBD. Results A total of 384 physicians responded to the questionnaire. The majority of Korean (n=70, 63.6%) and Chinese (n=51, 51.5%) physicians preferred vancomycin to metronidazole in the treatment of Clostridium difficile infection, whereas more than half of the Japanese physicians (n=62, 66.7%) preferred metronidazole. Physicians in Korea (n=88, 80.0%) and China (n=46, 46.5%) preferred a 3-month course of isoniazid and rifampin to treat latent tuberculosis infection, whereas most physicians in Japan (n=71, 76.3%) favored a 9-month course of isoniazid. Most Korean physicians (n=89, 80.9%) recommended hepatitis B virus (HBV) vaccination in patients lacking HBV surface antigen, whereas more than half of Japanese physicians (n=53, 57.0%) did not consider vaccination. Conclusions Differences in the diagnosis, prevention, and management of infections in patients with IBD across countries/regions reflect different prevalence rates of infectious diseases. This survey may broaden understanding of the real-world clinical settings across Asian countries/regions and provide information for establishing practical guidelines to manage patients with IBD. |
| first_indexed | 2024-03-12T17:51:54Z |
| format | Article |
| id | doaj.art-c57bb8d8265742db867d3bae4bfb5273 |
| institution | Directory Open Access Journal |
| issn | 1598-9100 2288-1956 |
| language | English |
| last_indexed | 2024-03-12T17:51:54Z |
| publishDate | 2023-07-01 |
| publisher | Korean Association for the Study of Intestinal Diseases |
| record_format | Article |
| series | Intestinal Research |
| spelling | doaj.art-c57bb8d8265742db867d3bae4bfb52732023-08-03T05:43:47ZengKorean Association for the Study of Intestinal DiseasesIntestinal Research1598-91002288-19562023-07-0121335336210.5217/ir.2023.000131014Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meetingYu Kyung Jun0Seong-Joon Koh1Dae Seong Myung2Sang Hyoung Park3Choon Jin Ooi4Ajit Sood5Jong Pil Im6 Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea Department of Gastroenterology, Chonnam National University Hwasun Hospital, Hwasun, Korea Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, KoreaBackground/Aims Infectious complications are major concerns when treating patients with inflammatory bowel disease (IBD). This study evaluated clinical differences across countries/regions in the management of infectious diseases in patients with IBD. Methods A multinational online questionnaire survey was administered to participants at the 8th meeting of the Asian Organization for Crohn’s and Colitis. The questionnaire included questions regarding surveillance, diagnosis, management, and prevention of infection in patients with IBD. Results A total of 384 physicians responded to the questionnaire. The majority of Korean (n=70, 63.6%) and Chinese (n=51, 51.5%) physicians preferred vancomycin to metronidazole in the treatment of Clostridium difficile infection, whereas more than half of the Japanese physicians (n=62, 66.7%) preferred metronidazole. Physicians in Korea (n=88, 80.0%) and China (n=46, 46.5%) preferred a 3-month course of isoniazid and rifampin to treat latent tuberculosis infection, whereas most physicians in Japan (n=71, 76.3%) favored a 9-month course of isoniazid. Most Korean physicians (n=89, 80.9%) recommended hepatitis B virus (HBV) vaccination in patients lacking HBV surface antigen, whereas more than half of Japanese physicians (n=53, 57.0%) did not consider vaccination. Conclusions Differences in the diagnosis, prevention, and management of infections in patients with IBD across countries/regions reflect different prevalence rates of infectious diseases. This survey may broaden understanding of the real-world clinical settings across Asian countries/regions and provide information for establishing practical guidelines to manage patients with IBD.http://irjournal.org/upload/pdf/ir-2023-00013.pdfinflammatory bowel diseasescytomegalovirus infectiontuberculosischronic viral hepatitis |
| spellingShingle | Yu Kyung Jun Seong-Joon Koh Dae Seong Myung Sang Hyoung Park Choon Jin Ooi Ajit Sood Jong Pil Im Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting Intestinal Research inflammatory bowel diseases cytomegalovirus infection tuberculosis chronic viral hepatitis |
| title | Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting |
| title_full | Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting |
| title_fullStr | Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting |
| title_full_unstemmed | Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting |
| title_short | Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting |
| title_sort | infectious complications in patients with inflammatory bowel disease in asia the results of a multinational web based survey in the 8th asian organization for crohn s and colitis meeting |
| topic | inflammatory bowel diseases cytomegalovirus infection tuberculosis chronic viral hepatitis |
| url | http://irjournal.org/upload/pdf/ir-2023-00013.pdf |
| work_keys_str_mv | AT yukyungjun infectiouscomplicationsinpatientswithinflammatoryboweldiseaseinasiatheresultsofamultinationalwebbasedsurveyinthe8thasianorganizationforcrohnsandcolitismeeting AT seongjoonkoh infectiouscomplicationsinpatientswithinflammatoryboweldiseaseinasiatheresultsofamultinationalwebbasedsurveyinthe8thasianorganizationforcrohnsandcolitismeeting AT daeseongmyung infectiouscomplicationsinpatientswithinflammatoryboweldiseaseinasiatheresultsofamultinationalwebbasedsurveyinthe8thasianorganizationforcrohnsandcolitismeeting AT sanghyoungpark infectiouscomplicationsinpatientswithinflammatoryboweldiseaseinasiatheresultsofamultinationalwebbasedsurveyinthe8thasianorganizationforcrohnsandcolitismeeting AT choonjinooi infectiouscomplicationsinpatientswithinflammatoryboweldiseaseinasiatheresultsofamultinationalwebbasedsurveyinthe8thasianorganizationforcrohnsandcolitismeeting AT ajitsood infectiouscomplicationsinpatientswithinflammatoryboweldiseaseinasiatheresultsofamultinationalwebbasedsurveyinthe8thasianorganizationforcrohnsandcolitismeeting AT jongpilim infectiouscomplicationsinpatientswithinflammatoryboweldiseaseinasiatheresultsofamultinationalwebbasedsurveyinthe8thasianorganizationforcrohnsandcolitismeeting |